Sheetal Kumar

Sheetal Kumar has extensive experience in regulatory affairs within the pharmaceutical industry, currently serving as a Regulatory Affairs Project Manager at Sanofi since March 2019, following a tenure as a Senior Regulatory Affairs Associate from January 2011 to December 2015. In this role, Sheetal Kumar has been the regulatory lead for renal and dyslipidemia brands, managing the submission and registration of new chemical entities at the TGA in Australia and Medsafe in New Zealand. Prior to this, Sheetal Kumar acted as Project Lead for oncology and cell/tissue therapy brands, overseeing product registrations from submission to approval in Australia and New Zealand. Earlier experience includes a position as a Prescription Medicine Evaluator at the Therapeutic Goods Administration, where responsibilities involved evaluating new product registrations and contributing to legislation and policy development for cell and tissue therapies. Sheetal Kumar holds a Bachelor of Medical Science (Honours 1) in Immunology from The Australian National University and completed additional Honours in Immunology at the John Curtin School of Medical Research.